Citigroup Inc. - Net Worth and Insider Trading

Citigroup Inc. Net Worth

The estimated net worth of Citigroup Inc. is at least $232 Million dollars as of 2025-03-02. Citigroup Inc. is the 2201 Interest of corporation controlled by you of Pharmaron Beijing Co Ltd and owns about 15,088,838 shares of Pharmaron Beijing Co Ltd (HKSE:03759) stock worth over $232 Million. Details can be seen in Citigroup Inc.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Citigroup Inc. has not made any transactions after 2023-09-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Citigroup Inc.

To

Citigroup Inc. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Citigroup Inc. owns 1 companies in total, including Pharmaron Beijing Co Ltd (HKSE:03759) .

Click here to see the complete history of Citigroup Inc.’s form 4 insider trades.

Insider Ownership Summary of Citigroup Inc.

Ticker Comapny Transaction Date Type of Owner
HKSE:03759 Pharmaron Beijing Co Ltd 2023-09-11 2201 Interest of corporation controlled by you

Citigroup Inc. Latest Holdings Summary

Citigroup Inc. currently owns a total of 1 stock. Citigroup Inc. owns 15,088,838 shares of Pharmaron Beijing Co Ltd (HKSE:03759) as of September 11, 2023, with a value of $232 Million.

Latest Holdings of Citigroup Inc.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:03759 Pharmaron Beijing Co Ltd 2023-09-11 15,088,838 15.38 232,066,328

Holding Weightings of Citigroup Inc.


Citigroup Inc. Form 4 Trading Tracker

According to the SEC Form 4 filings, Citigroup Inc. has made a total of 10 transactions in Pharmaron Beijing Co Ltd (HKSE:03759) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Pharmaron Beijing Co Ltd is the sale of 4,762,604 shares on September 11, 2023, which brought Citigroup Inc. around $0.

Insider Trading History of Citigroup Inc.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Citigroup Inc. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Citigroup Inc. Ownership Network

Ownership Network List of Citigroup Inc.

No Data

Ownership Network Relation of Citigroup Inc.

Insider Network Chart

Citigroup Inc. Owned Company Details

What does Pharmaron Beijing Co Ltd do?

Who are the key executives at Pharmaron Beijing Co Ltd?

Citigroup Inc. is the 2201 Interest of corporation controlled by you of Pharmaron Beijing Co Ltd. Other key executives at Pharmaron Beijing Co Ltd include 2201 Interest of corporation controlled by you Jpmorgan Chase & Co. , 2201 Interest of corporation controlled by you Morgan Stanley , and 2201 Interest of corporation controlled by you The Bank Of New York Mellon Corporation .

Pharmaron Beijing Co Ltd (HKSE:03759) Insider Trades Summary

Over the past 18 months, Citigroup Inc. made 4 insider transaction in Pharmaron Beijing Co Ltd (HKSE:03759) with a net sale of 0. Other recent insider transactions involving Pharmaron Beijing Co Ltd (HKSE:03759) include a net sale of 0 shares made by Morgan Stanley , a net purchase of 6,758,104 shares made by Jpmorgan Chase & Co. , and a net purchase of 779,500 shares made by The Bank Of New York Mellon Corporation .

In summary, during the past 3 months, insiders sold 0 shares of Pharmaron Beijing Co Ltd (HKSE:03759) in total and bought 2,262,327 shares, with a net purchase of 2,262,327 shares. During the past 18 months, 1,036,933 shares of Pharmaron Beijing Co Ltd (HKSE:03759) were sold and 8,574,537 shares were bought by its insiders, resulting in a net purchase of 7,537,604 shares.

Pharmaron Beijing Co Ltd (HKSE:03759)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Pharmaron Beijing Co Ltd Insider Transactions

No Available Data

Citigroup Inc. Mailing Address

Above is the net worth, insider trading, and ownership report for Citigroup Inc.. Currently GuruFocus does not have mailing address information for Citigroup Inc..